Hepatitis C virus-related acute and chronic hepatitis in hemodialysis patients.
The incidence of HCV antibodies has been evaluated in 123 chronic hemodialysis (HD) patients (Group A; 55 M and 68 F) and in 37 consecutive HD patients (group B) admitted to our hospitals for acute hepatitis. In group A, HCV antibodies were present in 27% of the patients. 20 of 36 (55%) had previously received blood transfusions. 21 patients (58%) were also positive for HBV Ab. In 8 patients, ALT were significantly increased. In group B, the diagnosis of HCV-related acute hepatitis was made in 11 patients. 8 of them had previously received blood transfusions. Seroconversion occurred 2-3 months after onset of the disease.
Pluvio
M
M
Istituto di Medicina Interna e Nefrologia, Ia Facoltà di Medicina e Chirurgia di Napoli, Italy.
Saggese
A
A
Cirillo
D
D
Castellino
P
P
Pempinello
R
R
Iannece
M D
MD
Guarnaccia
D
D
Tassinaro
P
P
Pluvio
C
C
Cicchella
T
T
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D016174:Hepacivirus / Q000276:immunology; D006508:Hepatitis Antibodies / Q000097:blood; D006510:Hepatitis B Antibodies / Q000097:blood; D006526:Hepatitis C / Q000276:immunology / Q000635:transmission*; D006521:Hepatitis, Chronic / Q000276:immunology; D006801:Humans; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects*; D012307:Risk Factors; D065227:Transfusion Reaction
D006508:Hepatitis Antibodies; D006510:Hepatitis B Antibodies